Beam Therapeutics Inc (BEAM)

SG&A Expense Growth

-7.21%

Quarterly · Period ending:

BEAM logo

BEAM SG&A Expense Growth

Latest reported-7.21%
BEAM Quarterly SG&A Growth (QoQ) (0.00% → -7.21%)
High-resolution chart · PNG

BEAM sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Beam Therapeutics Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
-7.209%
6.6607%
20.7143%
-0.4431%
-3.869%
-2.5122%
8.0898%
-10.5009%
10.8592%
-38.2204%
70.2361%
3.0581%
4.9638%
3.5669%
3.9697%
-9.3384%
25.0169%
8.2996%
12.6664%
17.6901%
30.4682%
22.971%
11.357%
8.1447%
1.835%
10.5844%
12.2654%
10.2471%
26.6735%
5.8744%
30.9457%
6.4813%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.